Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
260.8K
Cash
562K
Avg Qtr Burn
-2.377M
Short % of Float
2.40%
Insider Ownership
0.04%
Institutional Own.
7.41%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Prexigebersen (BP1001) Details Acute myeloid leukemia, Cancer | Phase 2 Data readout | |
BP1002 Details Acute myeloid leukemia, Blood cancer, Cancer | Phase 1 Data readout | |
BP1002 Details Lymphoma, Chronic lymphocytic leukemia, Blood cancer, Cancer | Phase 1 Data readout | |
BP1001-A Details Solid tumor/s, Cancer | Phase 1 Data readout |